Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 06-1995 | 06-1994 | 06-1993 | 06-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 233,000 | 75,102 | 55,000 | 63,000 | 24,000 |
| Marketable Securities | 1,041,000 | N/A | 2,708,000 | 2,434,000 | 1,725,000 |
| Inventories | 811,000 | 757,924 | 575,000 | 595,000 | 475,000 |
| Other current assets | 2,084,000 | 2,902,653 | 1,190,000 | 1,196,000 | 986,000 |
| TOTAL | $4,280,000 | $3,735,678 | $4,648,000 | $4,438,000 | $3,309,000 |
| Non-Current Assets | |||||
| PPE Net | 4,165,000 | 4,242,300 | 3,184,000 | 2,959,000 | 2,341,000 |
| Other Non-Current Assets | 96,000 | 124,144 | 55,000 | 61,000 | 32,000 |
| TOTAL | $4,261,000 | $4,366,444 | $3,239,000 | $3,020,000 | $2,373,000 |
| Total Assets | $8,541,000 | $8,102,121 | $7,887,000 | $7,458,000 | $5,682,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,004,000 | 919,179 | 400,000 | 597,000 | 366,000 |
| Accounts payable and accrued liabilities | 293,000 | 2,248,779 | 188,000 | 178,000 | 162,000 |
| TOTAL | $5,466,000 | $3,167,957 | $2,130,000 | $2,200,000 | $1,568,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,466,000 | 3,260,076 | 272,000 | 212,000 | 137,000 |
| Other Non-Current Liabilities | 1,228,000 | 935,191 | 83,000 | 85,000 | 92,000 |
| TOTAL | $2,854,000 | $4,359,473 | $608,000 | $601,000 | $475,000 |
| Total Liabilities | $8,320,000 | $7,527,431 | $2,738,000 | $2,801,000 | $2,043,000 |
| Shareholders' Equity | |||||
| Common Shares | 876,000 | N/A | 762,000 | 758,000 | 753,000 |
| Retained earnings | N/A | 4,098,125 | N/A | N/A | N/A |
| Other shareholders' equity | -1,158,000 | -3,687,640 | 4,035,000 | 3,637,000 | 2,742,000 |
| TOTAL | $91,000 | $410,484 | $5,026,000 | $4,546,000 | $3,572,000 |
| Total Liabilities And Equity | $8,411,000 | $7,937,915 | $7,764,000 | $7,347,000 | $5,615,000 |